LONDON — A new statistical model developed by scientists at the Francis Crick Institute revealed 27 novel genes thought to prevent cancer from forming, in an analysis of over 2000 tumors across 12 human cancer types. The findings could help create new cancer treatments that target these genes, and open…...
NFCR Leads Delegation to Chinese BioMed Conference, Signs MOU with Host
The National Foundation for Cancer Research, led by Chairman Joseph F. Franlin and President Sujuan Ba, recruited a delegation of eight U.S. cancer technology start-ups for a successful exploratory mission to China. The companies—ArrayBio, Eutropics, Immix Biopharma, InterLeukin Therapeutics, International Cancer Impact Fund, InVaMet Therapeutics, Nonpareil Biotechnologies and Stromatis Pharma—were…...
Firefighters: Heroes in the Line of Fire
All consuming, unforgiving, destructive: adjectives easily attributable to the symptoms, treatments, diagnosis and battle with cancer. These descriptors also paint an accurate rendering of the infernos into which American fire fighters, America’s Bravest, venture unflinchingly as they perform their duty. In a recent exposé, experts uncovered a disturbing trend which…...
Novel CAR-T Treatment Approved for Second Indication
In the past two months, the FDA has approved a revolutionary new form of immunotherapy, called chimeric antigen receptor (CAR) T cell therapy, for two blood cancers: B cell acute lymphoblastic leukemia (ALL) in August, 2017 and now on October 18th, for aggressive diffuse large B cell lymphoma (DLBCL), a…...
Strategic Media Partner
